The ACME Laboratories Ltd. announcements
156 Dhaka Stock Exchange announcements for The ACME Laboratories Ltd. (ACMELAB) since 2016: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (19).
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the rating of the Company as "AA" in the long term and "ST-2" in the short term along with Stable outlook in consideration of its audited financials up to June 30, 2024; unaudited financials up to September 30, 2024 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Sale Confirmation of a Sponsor
Ms. Parveen Akhter Khanam, a sponsor of the company, has further informed that she has completed her sale of 2,200,000 shares of the Company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 02.12.2024 and 04.12.2024.
- Sale Declaration of a Sponsor
Refer to BSEC's letter no. BSEC/ICAD/SRIC/80-2016/Part-3/260 dated November 27, 2024, Ms. Parveen Akhter Khanam, a sponsor of the company, has expressed her intention to sell 20,00,000 shares out of her total holding of 65,19,158 shares of the Company at prevailing market price (In the Public and/or Block Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- Sale Declaration of a Sponsor
Refer to BSEC's letter no. BSEC/ICAD/SRIC/80-2016/Part-3/260 dated November 27, 2024, Ms. Parveen Akhter Khanam, a sponsor of the company, has expressed her intention to sell 200,000 shares out of her total holding of 65,19,158 shares of the Company at prevailing market price (In the Public/Block Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- BSEC Instructs to sell shares of Ms. Parveen Akhter Khanom
To offset the deficit created in the Consolidated Customer's Account (CCA) of Sinha Securities Ltd., BSEC has instructed Ms. Parveen Akhter Khanom (Sponsor Shareholder of the company and also the Chairman of Sinha Securities Ltd.) to sell 22,00,000 shares of The ACME Laboratories Limited.
- Resumption after Record date
Trading of the shares of the company will resume on 21.11.2024.
- Suspension for record date
Trading of the shares of the company will remain suspended on record date i.e., 20.11.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 18.11.2024 to 19.11.2024. Trading of the shares of the company will remain suspended on record date i.e., 20.11.2024.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 2.61 for July-September 2024 as against Tk. 3.11 for July-September 2023; NOCFPS was Tk. 6.44 for July-September 2024 as against Tk. 2.93 for July-September 2023. NAV per share was Tk. 121.02 as on September 30, 2024 and Tk. 118.39 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- Dividend Declaration
The Board of Directors has recommended 35% Cash Dividend for the year ended June 30, 2024. Date of AGM: 23.12.2024, Time: 11:30 AM, Venue: Digital Platform. Record Date: 20.11.2024. The Company has also reported EPS of Tk. 11.61, NAV per share of Tk. 118.39 and NOCFPS of Tk. 9.24 for the year ended June 30, 2024 as against Tk. 10.89, Tk. 110.09 and Tk. 5.95 respectively for the year ended June 30, 2023.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (28.10.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2024 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Board approval for production of validation batch of the API
The company has informed that the Board of Directors of the company passed the following decision: Approval for production of validation batch of the Active Pharmaceutical Ingredients (API) project of the company at API Industrial Park, Baushia, Gazaria, Munshiganj.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 2.75 for January-March 2024 as against Tk. 2.53 for January-March 2023; EPS was Tk. 8.53 for July 2023-March 2024 as against Tk. 7.98 for July 2022-March 2023. NOCFPS was Tk. 5.77 for July 2023-March 2024 as against Tk. 6.82 for July 2022-March 2023. NAV per share was Tk. 115.32 as on March 31, 2024 and Tk. 110.09 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2024 at 03:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 2.67 for October-December 2023 as against Tk. 2.52 for October-December 2022; EPS was Tk. 5.78 for July-December 2023 as against Tk. 5.45 for July-December 2022. NOCFPS was Tk. 5.02 for July-December 2023 as against Tk. 6.09 for July-December 2022. NAV per share was Tk. 112.57 as on December 31, 2023 and Tk. 110.09 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shareholders.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.